Personalis, Inc. Profile Avatar - Palmy Investing

Personalis, Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides…

Medical - Diagnostics & Research
US, Menlo Park [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PSNL's Analysis
CIK: 1527753 CUSIP: 71535D106 ISIN: US71535D1063 LEI: - UEI: -
Secondary Listings
PSNL has no secondary listings inside our databases.